Micreos

Micreos company information, Employees & Contact Information

Explore related pages

Related company profiles:

Micreos is a platform biotech company focused on discovering and developing recombinant proteins for chronic dermatological disease Micreos is a clinical-stage pharmaceutical biotech developing medicinal solutions that selectively kill only harmful bacteria while preserving the rest of the health-enhancing microbiome. Our vision is to positively impact patient care while helping global health care systems to address impending anti-microbial resistance (AMR) concerns. Our unique capability in modular engineering to optimize enzyme therapeutics means that we have already developed three endolysin-based investigational antimicrobials. These antimicrobials are focused on the detrimental impact of Staphylococcus aureus (S. aureus) in oncology, dermatology and bloodstream infections. Our team is forging ahead, partnering across medicine, to realize the shared goal of better solutions to combat harmful bacteria in an era of antimicrobial resistance. Welcome to Micreos. Beyond resistance

Company Details

Employees
16
Founded
-
Address
Neuhofstrasse 12, Baar,zug 6340,switzerland
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
Keywords
London.
HQ
Baar, Zug
Looking for a particular Micreos employee's phone or email?

Micreos Questions

News

Creating New Targeted Antibacterial Products to Help Tackle Antimicrobial Resistance - News-Medical

Creating New Targeted Antibacterial Products to Help Tackle Antimicrobial Resistance News-Medical

Micreos Raises €30 Million for Endolysin Technology Set to Replace Antibiotics - PR Newswire

Micreos Raises €30 Million for Endolysin Technology Set to Replace Antibiotics PR Newswire

Micreos taps Northway Biotech to tackle eczema at the source - BioProcess International

Micreos taps Northway Biotech to tackle eczema at the source BioProcess International

Micreos Pharmaceuticals Partners With Biologics CDMO Northway Biotech for Its Engineered Endolysin Therapeutic Manufacturing Program - BioSpace

Micreos Pharmaceuticals Partners With Biologics CDMO Northway Biotech for Its Engineered Endolysin Therapeutic Manufacturing Program BioSpace

Micreos sidesteps antibiotic resistance, targeting superbugs with $37M for endolysin - BioWorld MedTech

Micreos sidesteps antibiotic resistance, targeting superbugs with $37M for endolysin BioWorld MedTech

L'Oréal x Micreos Collaborate on Biotech and Skin Research - Cosmetics & Toiletries

L'Oréal x Micreos Collaborate on Biotech and Skin Research Cosmetics & Toiletries

L’Oréal partners with biotech company Micreos for skin-related technology - BW Confidential

L’Oréal partners with biotech company Micreos for skin-related technology BW Confidential

Listeria Cheese Sickens Mom and Kills Baby - Food Poison Journal

Listeria Cheese Sickens Mom and Kills Baby Food Poison Journal

L'Oréal’s microbiome skin care R&D receives boost with Micreos deal - NutraIngredients.com

L'Oréal’s microbiome skin care R&D receives boost with Micreos deal NutraIngredients.com

Battle versus bacteria heats up - The National Provisioner

Battle versus bacteria heats up The National Provisioner

Could enzymes called endolysins ease eczema symptoms and offer an alternative to antibiotics? - BBC

Could enzymes called endolysins ease eczema symptoms and offer an alternative to antibiotics? BBC

L'Oréal signs license agreement with Dutch biotech Micreos, world leader in targeted bacterial biotechnology - PR Newswire

L'Oréal signs license agreement with Dutch biotech Micreos, world leader in targeted bacterial biotechnology PR Newswire

Micreos Secures €12 Million for New Products Containing Staphefekt; Alternative to Antibiotics Can Help Millions - PR Newswire UK

Micreos Secures €12 Million for New Products Containing Staphefekt; Alternative to Antibiotics Can Help Millions PR Newswire UK

FDA Approves PhageGuard-E as New Food Processing Aid Against E. Coli O157 - PR Newswire

FDA Approves PhageGuard-E as New Food Processing Aid Against E. Coli O157 PR Newswire

Micreos Pharmaceuticals announces success of its XZ.700 technology in selectively eliminating Staphylococcus aureus pathogen without triggering resistance - PR Newswire

Micreos Pharmaceuticals announces success of its XZ.700 technology in selectively eliminating Staphylococcus aureus pathogen without triggering resistance PR Newswire

Micreos appoints Matt Regan as CEO of its Pharmaceutical business - PR Newswire

Micreos appoints Matt Regan as CEO of its Pharmaceutical business PR Newswire

Micreos initiates clinical trial to evaluate world's first endolysin-drug as a therapy for Atopic Dermatitis - PR Newswire

Micreos initiates clinical trial to evaluate world's first endolysin-drug as a therapy for Atopic Dermatitis PR Newswire

Take off the heat - FoodEngineeringMag.com

Take off the heat FoodEngineeringMag.com

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant